LANHUA MA CAME, MD, PhD
*** ******** ** * Arlington, MA 02474 * 617-***-**** * US Citizen * *******@*****.***
EXPERIENCE
**** – Present UI Corporation / PrimeraDx, Mansfield, MA
Medical Scientist
Developing novel molecular diagnostics for infectious disease management.
2009 – 2010 Observership/Externership (at multiple clinics and hospitals)
2004 – 2008 Brandeis University, Waltham, MA
Postdoctoral Fellow
Studying the working mechanism of Modafinil in the treatment of Narcolepsy.
2001 – 2004 Eunice Kennedy Shriver Center, Waltham, MA
Postdoctoral Research Associate
Investigating possible teratogenicity of hypergravity on human/astronaut brain development (a NASA project).
CERTIFICATIONS
ECFMG Certification, 2009-2010
United States Medical License Examination: passed USMLE Step 1, Step 2 CK, Step 2 CS, and Step 3.
EDUCATION
PhD, Pathology, 2000
Department of Pathology, Fourth Military Medical University, Xi'an, Shaanxi, China
Research: Creating "biological missile" in the form of monoclonal antibody conjugated with toxin to cure hepatocellular carcinoma.
Master of Medical Science, Pathology, 1997
Department of Pathology, Inner Mongolia Medical College and Beijing Medical University, China
Research: Exploring novel immunohistochemistry methods to diagnose Non-Hodgkin's lymphoma.
MD, Clinical Medicine, 1994
Inner Mongolia Medical College, Hohhot, Inner Mongolia, China
PUBLICATIONS
Came L etc. (2008) Gene expression of cholinergic neuron in the mouse basal forebrain during sleep deprivation and recovery sleep. J. Neuroscience (pending)
Ma L, Hong SJ, McCaffery P. (2005) Influence of 2g gravity on the midgestational gene expression in the embryonic hindbrain. Neurotoxicol Teratol. 2005 Nov-Dec;27(6):897
...Ma L, McCaffery P. (2003) The Meninges Is a Source of Retinoic Acid for the Late-Developing Hindbrain. J. Neuroscience,23(20):7610-7620
Ma L, Sun ZW, Liu YF. (2000) Expression and purification and targeting therapy of mscFv25-TNF against Hepatocellular Carcinoma. J Med Coll PLA,15:121-124.
Ma L, Sun ZW, Liu YF. (2000) Targeting Therapy of Recombinant Single Chain Fv Fused to TNF (mscFv25-TNF). J Cell Mol Immunol, 16:501-504.
Ma L, Wang GJ, Dong YC. (1999) Expression of PCNA in Non-Hodgkin's Lymphoma. Advance of cancer research in China (Monograph), 5:444-447.